Go Pro

Ovid Therapeutics (OVID) Institutional Ownership

Ovid Therapeutics logo
$2.38 -0.05 (-2.06%)
Closing price 04:00 PM Eastern
Extended Trading
$2.45 +0.07 (+2.94%)
As of 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for Ovid Therapeutics (NASDAQ:OVID)

Current
Institutional Ownership
Percentage
72.24%
Number of
Institutional Buyers
(last 12 months)
52
Total
Institutional Inflows
(last 12 months)
$228.30M
Number of
Institutional Sellers
(last 12 months)
17
Total
Institutional Outflows
(last 12 months)
$10.54M
Get OVID Insider Trade Alerts

Want to know when executives and insiders are buying or selling Ovid Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

OVID Institutional Buying and Selling by Quarter

Ovid Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
9/9/2026Squarepoint Ops LLC18,937$51K0.0%-90.4%0.010%
9/8/2026Spark Investment Management LLC31,800$86K0.2%N/A0.016%
8/21/2026Braidwell LP5,919,464$15.92M0.6%N/A3.031%
8/21/2026Velan Capital Investment Management LP130,000$350K0.2%-18.8%0.067%
8/20/2026Two Sigma Securities LLC71,487$192K0.0%+182.3%0.037%
8/19/2026Wellington Management Group LLP103,400$278K0.0%N/A0.053%
8/18/2026Empowered Funds LLC91,234$245K0.0%N/A0.047%
8/18/2026Stonepine Capital Management LLC21,300$57.30K0.0%N/A0.011%
8/17/2026Bank of America Corp DE409,490$1.10M0.0%N/A0.210%
8/15/2026Jupiter Topco LLC20,741,234$55.90M0.0%N/A11.113%
8/14/2026ADAR1 Capital Management LLC7,417,479$19.95M0.9%N/A3.974%
8/14/2026Parkman Healthcare Partners LLC197,947$532K0.1%N/A0.106%
8/14/2026Legal & General Group Plc14,858$40K0.0%N/A0.008%
8/14/2026The Manufacturers Life Insurance Company40,910$110K0.0%N/A0.022%
8/13/2026Cibc World Market Inc.218,851$589K0.0%N/A0.117%
8/11/2026E Fund Management Co. Ltd.19,286$52K0.0%N/A0.010%
8/7/2026BlackRock Inc.10,823,480$29.12M0.0%N/A5.799%
8/7/2026Deutsche Bank AG149,391$402K0.0%N/A0.080%
8/6/2026Bank of New York Mellon Corp416,318$1.12M0.0%N/A0.223%
8/6/2026Focus Partners Advisor Solutions LLC20,000$54K0.0%N/A0.011%
8/6/2026State of Wyoming53,438$144K0.0%N/A0.029%
7/8/2026Assenagon Asset Management S.A.17,544$47K0.0%-92.3%0.009%
5/19/2026Bank of America Corp DE290,432$645K0.0%+49.0%0.220%
5/19/2026Janus Henderson Group PLC10,714,000$23.73M0.0%N/A8.124%
5/19/2026Ally Bridge Group NY LLC2,818,459$6.26M5.1%+57.9%2.137%
5/18/2026ADAR1 Capital Management LLC4,544,113$10.09M0.6%+6.0%3.446%
5/15/2026OMERS ADMINISTRATION Corp100,100$222K0.0%-20.1%0.076%
5/15/2026Affinity Asset Advisors LLC10,636,318$23.61M1.2%+48.8%8.065%
5/14/2026Renaissance Technologies LLC1,104,300$2.45M0.0%-25.6%0.837%
5/14/2026Sei Investments Co.328,924$730K0.0%N/A0.249%
5/14/2026Walleye Capital LLC443,362$984K0.0%-16.3%0.336%
5/14/2026State of Wyoming22,171$49K0.0%N/A0.017%
4/27/2026Simplify Asset Management Inc.130,813$290K0.0%N/A0.099%
4/20/2026Assenagon Asset Management S.A.227,742$506K0.0%-63.1%0.173%
4/17/2026Total Clarity Wealth Management Inc.20,975$47K0.0%-26.7%0.016%
4/17/2026Sovereign Financial Group Inc.30,000$67K0.0%+200.0%0.023%
2/19/2026Invesco Ltd.33,308$54K0.0%N/A0.047%
2/18/2026ADAR1 Capital Management LLC4,285,000$6.99M0.5%+33,256.7%6.017%
2/18/2026Ikarian Capital LLC247,558$404K0.0%-77.4%0.348%
2/18/2026Quadrature Capital Ltd87,874$143K0.0%+217.2%0.123%
How options let you do more with less capital (Ad)

Would you rather spend $5,000 buying 100 shares of a $50 stock, or control those same 100 shares for a fraction of the cost? That's the core advantage options offer traders at every level. The Beginner's Guide to Options breaks down leverage, income strategies, and real trade examples in plain English — including a little-known approach many traders use to reduce costs and improve profit potential. Download your free copy before this offer expires.tc pixel

Claim your free copy of The Beginner's Guide to Options now
2/18/2026Millennium Management LLC1,339,465$2.18M0.0%+35.8%1.881%
2/18/2026Balyasny Asset Management L.P.325,000$530K0.0%-48.0%0.456%
2/18/2026Boothbay Fund Management LLC155,741$254K0.0%-68.0%0.219%
2/17/2026ADAR1 Capital Management LLC4,285,000$6.99M0.5%+33,256.7%6.017%
2/17/2026Schonfeld Strategic Advisors LLC192,496$314K0.0%-78.2%0.270%
2/17/2026Ally Bridge Group NY LLC1,785,000$2.91M3.0%N/A2.507%
2/17/2026RA Capital Management L.P.10,714,000$17.46M0.2%N/A15.046%
2/17/2026Adage Capital Partners GP L.L.C.3,492,000$5.69M0.0%+158.7%4.904%
2/17/2026Graham Capital Management L.P.127,459$208K0.0%N/A0.179%
2/16/2026Squarepoint Ops LLC39,034$64K0.0%-66.0%0.055%
2/16/2026OMERS ADMINISTRATION Corp125,300$204K0.0%N/A0.176%
2/16/2026Eventide Asset Management LLC4,285,000$6.99M0.1%N/A6.017%
2/13/2026Marshall Wace LLP1,271,487$2.07M0.0%+62.3%1.786%
2/13/2026Walleye Capital LLC530,020$864K0.0%-11.2%0.744%
2/13/2026Affinity Asset Advisors LLC7,150,000$11.65M0.7%+169.8%10.041%
2/13/2026AWM Investment Company Inc.899,200$1.47M0.1%N/A1.263%
2/13/2026State Street Corp276,533$451K0.0%+21.8%0.388%
2/13/2026Wells Fargo & Company MN720,848$1.18M0.0%-1.4%1.012%
2/12/2026Jane Street Group LLC883,867$1.44M0.0%+270.7%1.241%
2/12/2026Renaissance Technologies LLC1,484,478$2.42M0.0%-26.4%2.085%
2/12/2026Federated Hermes Inc.3,571,000$5.31M0.0%N/A5.015%
2/11/2026LPL Financial LLC30,000$49K0.0%+150.0%0.042%
2/10/2026Goldman Sachs Group Inc.170,457$278K0.0%+497.7%0.239%
2/9/2026Geode Capital Management LLC672,004$1.10M0.0%+3.7%0.944%
2/2/2026Total Clarity Wealth Management Inc.28,600$47K0.0%N/A0.040%
1/12/2026Benin Management CORP19,000$31K0.0%N/A0.027%
1/9/2026Assenagon Asset Management S.A.618,019$1.01M0.0%-33.2%0.868%
11/17/2025Qube Research & Technologies Ltd25,277$33K0.0%-65.3%0.035%
11/17/2025Parkman Healthcare Partners LLC202,978$264K0.0%N/A0.285%
11/17/2025Millennium Management LLC986,293$1.28M0.0%-6.3%1.385%
11/17/2025Integrated Wealth Concepts LLC52,900$69K0.0%N/A0.074%
11/17/2025Bank of America Corp DE362,707$472K0.0%+2,333.0%0.509%
11/17/2025Boothbay Fund Management LLC486,877$633K0.0%N/A0.684%
11/14/2025Schonfeld Strategic Advisors LLC883,154$1.15M0.0%N/A1.240%
11/14/2025Two Sigma Investments LP341,134$443K0.0%N/A0.480%
11/14/2025Squarepoint Ops LLC114,923$149K0.0%-48.0%0.162%
11/13/2025Kennedy Capital Management LLC1,106,638$1.44M0.0%-26.3%1.556%
11/13/2025Private Advisor Group LLC25,600$33K0.0%N/A0.036%
11/10/2025Persistent Asset Partners Ltd46,040$60K0.0%N/A0.065%
11/7/2025GSA Capital Partners LLP265,993$346K0.0%-64.2%0.374%
11/7/2025Vanguard Group Inc.2,820,813$3.67M0.0%+7.0%3.967%
11/4/2025TLS Advisors LLC18,858$26K0.1%-97.2%0.027%
10/17/2025Apollon Wealth Management LLC27,500$36K0.0%N/A0.039%
10/7/2025Assenagon Asset Management S.A.924,576$1.20M0.0%+112.2%1.300%
8/15/2025Rosalind Advisors Inc.500,000$165K0.1%N/A0.703%
8/15/2025Rubric Capital Management LP478,533$158K0.0%-91.0%0.673%
8/14/2025Jane Street Group LLC142,597$47K0.0%N/A0.201%
8/14/2025Velan Capital Investment Management LP160,000$53K0.1%+64.9%0.225%
8/13/2025Marshall Wace LLP164,721$54K0.0%N/A0.232%
8/13/2025Kennedy Capital Management LLC1,502,329$496K0.0%-13.3%2.113%
WATCH THIS BEFORE DECEMBER 8th!! (Ad)

James Altucher says a quiet government filing could reveal Elon Musk's biggest move yet, and almost nobody has noticed it. Altucher believes the filing could matter to as many as 1,806,000 Americans in the years ahead. He explains why Musk buried it and what it could mean, free of charge.tc pixel

Watch the free breakdown before December 8th to learn more
8/8/2025Geode Capital Management LLC643,335$212K0.0%-51.7%0.905%
8/1/2025Y Intercept Hong Kong Ltd160,306$53K0.0%N/A0.225%
7/11/2025Assenagon Asset Management S.A.435,620$144K0.0%-22.3%0.613%
6/27/2025Goldman Sachs Group Inc.104,435$33K0.0%-47.3%0.147%
5/21/2025Acadian Asset Management LLC2,088,046$650K0.0%+12.8%2.936%
5/16/2025Goldman Sachs Group Inc.104,435$33K0.0%-47.3%0.147%
5/16/2025Jacobs Levy Equity Management Inc.200,593$63K0.0%-31.2%0.282%
5/16/2025Adage Capital Partners GP L.L.C.1,150,000$359K0.0%+15.0%1.617%
5/14/2025Affinity Asset Advisors LLC667,516$208K0.0%N/A0.939%
5/12/2025Nuveen LLC119,113$37K0.0%N/A0.168%


OVID Institutional Ownership - Frequently Asked Questions

During the previous two years, 82 institutional investors and hedge funds held shares of Ovid Therapeutics. The most heavily invested institutionals were Jupiter Topco LLC ($55.90M), BlackRock Inc. ($29.12M), Janus Henderson Group PLC ($23.73M), Affinity Asset Advisors LLC ($23.61M), ADAR1 Capital Management LLC ($19.95M), RA Capital Management L.P. ($17.46M), and Braidwell LP ($15.92M).Learn more on Ovid Therapeutics' institutional investors.

72.24% of Ovid Therapeutics' stock is owned by institutional investors. Learn more on OVID's institutional investor holdings.

Of the 71 institutional investors that purchased Ovid Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Jupiter Topco LLC ($20.74M), ADAR1 Capital Management LLC ($16.31M), BlackRock Inc. ($10.82M), Janus Henderson Group PLC ($10.71M), RA Capital Management L.P. ($10.71M), Affinity Asset Advisors LLC ($8.65M), and Takeda Pharmaceutical Co. Ltd. ($7.53M).

Institutional investors have bought a total of 104,468,237 shares in the last 24 months. This purchase volume represents approximately $228.30M in transactions.

Of the 17 institutional investors that sold Ovid Therapeutics' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Renaissance Technologies LLC ($913.72K), Assenagon Asset Management S.A. ($907.03K), Ikarian Capital LLC ($848.02K), Schonfeld Strategic Advisors LLC ($690.66K), TLS Advisors LLC ($662.11K), GSA Capital Partners LLP ($476.20K), and Kennedy Capital Management LLC ($395.69K).

Institutional investors have sold a total of 6,225,242 shares in the last 24 months. This volume of shares sold represents approximately $10.54M in transactions.



Institutional ownership data for NASDAQ:OVID is compiled from quarterly 13F filings submitted to the U.S. Securities and Exchange Commission (SEC), with the most recent received on 9/9/2026. New 13F filings are added each quarter as they're published.
From Our Partners